Investor Tang Capital Management Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Tang Capital Management Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-09-03 13D/A ITOS / iTeos Therapeutics, Inc. 3,826,692 10,000
2025-08-21 13D/A CRGX / CARGO Therapeutics, Inc. 3,059,630 10,000
2025-08-14 13G/A BOLT / Bolt Biotherapeutics, Inc. 3,812,773 166,879
2025-08-14 13G/A CTMX / CytomX Therapeutics, Inc. 6,717,825 11,065,662
2025-08-14 13G/A RVPH / Reviva Pharmaceuticals Holdings, Inc. 3,910,304 3,399,975
2025-08-14 13G/A OTLK / Outlook Therapeutics, Inc. 1,900,000 1,500,000
2025-08-14 13G/A CMPX / Compass Therapeutics, Inc. 11,052,632 13,496,208
2025-08-14 13G/A ELEV / Elevation Oncology, Inc. 6,043,921 3,115,000
2025-07-30 13G EPIX / ESSA Pharma Inc. 4,300,000 4,300,000
2025-07-22 13D/A ITOS / iTeos Therapeutics, Inc. 3,826,692 3,826,692
2025-07-09 13D/A CRGX / CARGO Therapeutics, Inc. 2,729,288 3,059,630
2025-06-12 13D ITOS / iTeos Therapeutics, Inc. 3,826,692 3,826,692
2025-05-23 13D/A SLRN / Acelyrin, Inc. 8,824,693 0
2025-05-19 13D/A ALLK / Allakos Inc. 8,693,687 10,000
2025-05-15 13G/A DTIL / Precision BioSciences, Inc. 623,332 673,332
2025-05-15 13G/A ELEV / Elevation Oncology, Inc. 6,043,921
2025-05-15 13G/A ACET / Adicet Bio, Inc. 8,216,960 8,223,612
2025-05-15 13G ITOS / iTeos Therapeutics, Inc. 221,716 3,826,692
2025-05-15 13G/A TARS / Tarsus Pharmaceuticals, Inc. 2,454,797
2025-05-15 13G/A KALV / KalVista Pharmaceuticals, Inc. 4,321,547 4,941,798
2025-05-15 13G/A BOLT / Bolt Biotherapeutics, Inc. 3,812,773
2025-05-15 13G/A CTMX / CytomX Therapeutics, Inc. 7,811,760 6,717,825
2025-05-15 13G/A EOLS / Evolus, Inc. 4,847,399 4,997,399
2025-05-15 13G/A CMPX / Compass Therapeutics, Inc. 7,400,000 11,052,632
2025-05-15 13G/A RVPH / Reviva Pharmaceuticals Holdings, Inc. 3,910,304
2025-05-15 13G/A OTLK / Outlook Therapeutics, Inc. 1,900,000
2025-05-15 13G/A DERM / Journey Medical Corporation 1,523,938 1,854,596
2025-05-15 13G/A CYBN / Cybin Inc. 1,330,097 1,830,097
2025-05-15 13G/A ALXO / ALX Oncology Holdings Inc. 3,158,265
2025-05-02 13D HLVX / HilleVax, Inc. 4,920,000
2025-05-01 13G SYRE / Spyre Therapeutics, Inc. 3,200,000
2025-04-17 13D/A ALLK / Allakos Inc. 8,693,687 8,693,687
2025-04-04 13G KNSA / Kiniksa Pharmaceuticals, Ltd. 2,178,609
2025-04-03 13D/A ALLK / Allakos Inc. 8,693,440 8,693,687
2025-03-12 13D/A SLRN / Acelyrin, Inc. 7,298,328 8,824,693
2025-03-10 13D PLRX / Pliant Therapeutics, Inc. 5,859,044
2025-03-04 13D/A AUPH / Aurinia Pharmaceuticals Inc. 7,229,500 10,029,500
2025-02-27 13D/A SLRN / Acelyrin, Inc. 5,298,328 7,298,328
2025-02-21 13D CRGX / CARGO Therapeutics, Inc. 2,729,288
2025-02-20 13D SLRN / Acelyrin, Inc. 5,298,328
2025-02-14 13D GLPG / Galapagos NV - Depositary Receipt (Common Stock) 4,910,525
2025-02-14 13G/A CYBN / Cybin Inc. 1,105,433 1,330,097
2025-02-14 13G/A MNPR / Monopar Therapeutics Inc. 200,000 0
2025-02-14 13G/A ITOS / iTeos Therapeutics, Inc. 2,407,800 221,716
2025-02-03 13D ALLK / Allakos Inc. 8,693,440
2025-01-27 13G NKTX / Nkarta, Inc. 7,014,100
2025-01-16 13G CMPX / Compass Therapeutics, Inc. 7,400,000
2024-12-03 13G CYBN / Cybin Inc. 1,105,433
2024-11-29 13G DERM / Journey Medical Corporation 1,523,938
2024-11-14 13G LIANY / LianBio - Depositary Receipt (Common Stock) 8,051,815
2024-11-14 13G/A KALV / KalVista Pharmaceuticals, Inc. 4,321,547
2024-11-14 13G/A DTIL / Precision BioSciences, Inc. 623,332
2024-11-14 13G/A ANAB / AnaptysBio, Inc. 1,330,879
2024-11-14 13G/A CRBP / Corbus Pharmaceuticals Holdings, Inc. 600,000
2024-11-14 13G/A OKUR / OnKure Therapeutics, Inc. 294,626
2024-11-14 13G/A QNCX / Quince Therapeutics, Inc. 0
2024-11-14 13G/A ACET / Adicet Bio, Inc. 8,216,960
2024-11-14 13G/A BCAB / BioAtla, Inc. 874,076
2024-11-14 13G/A LENZ / LENZ Therapeutics, Inc. 766,940
2024-11-14 13G/A CTMX / CytomX Therapeutics, Inc. 7,811,760
2024-11-14 13G/A EOLS / Evolus, Inc. 4,847,399
2024-11-08 13D EPIX / ESSA Pharma Inc. 4,300,000
2024-10-24 13G MNPR / Monopar Therapeutics Inc. 200,000
2024-10-08 13D KZR / Kezar Life Sciences, Inc. 7,200,000
2024-09-30 13G ITOS / iTeos Therapeutics, Inc. 2,407,800
2024-09-18 13D OMIC / Singular Genomics Systems, Inc. 372,000
2024-09-12 13D AUPH / Aurinia Pharmaceuticals Inc. 7,229,500
2022-04-21 13G ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) 18,796,125
2022-04-21 13G US45791E1073 / INSPIRATO INC 2,432,600